Copyright Reports & Markets. All rights reserved.

Global Testosterone Replacement Therapy Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Testosterone Replacement Therapy Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Testosterone Replacement Therapy Market Size Growth Rate by Product
      • 1.4.2 Gels
      • 1.4.3 Injections
      • 1.4.4 Patches
      • 1.4.5 Other
    • 1.5 Market by End User
      • 1.5.1 Global Testosterone Replacement Therapy Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Testosterone Replacement Therapy Market Size
      • 2.1.1 Global Testosterone Replacement Therapy Revenue 2014-2025
      • 2.1.2 Global Testosterone Replacement Therapy Sales 2014-2025
    • 2.2 Testosterone Replacement Therapy Growth Rate by Regions
      • 2.2.1 Global Testosterone Replacement Therapy Sales by Regions
      • 2.2.2 Global Testosterone Replacement Therapy Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Testosterone Replacement Therapy Sales by Manufacturers
      • 3.1.1 Testosterone Replacement Therapy Sales by Manufacturers
      • 3.1.2 Testosterone Replacement Therapy Sales Market Share by Manufacturers
      • 3.1.3 Global Testosterone Replacement Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Testosterone Replacement Therapy Revenue by Manufacturers
      • 3.2.1 Testosterone Replacement Therapy Revenue by Manufacturers (2014-2019)
      • 3.2.2 Testosterone Replacement Therapy Revenue Share by Manufacturers (2014-2019)
    • 3.3 Testosterone Replacement Therapy Price by Manufacturers
    • 3.4 Testosterone Replacement Therapy Manufacturing Base Distribution, Product Types
      • 3.4.1 Testosterone Replacement Therapy Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Testosterone Replacement Therapy Product Type
      • 3.4.3 Date of International Manufacturers Enter into Testosterone Replacement Therapy Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Testosterone Replacement Therapy Sales by Product
    • 4.2 Global Testosterone Replacement Therapy Revenue by Product
    • 4.3 Testosterone Replacement Therapy Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Testosterone Replacement Therapy Breakdown Data by End User

    6 North America

    • 6.1 North America Testosterone Replacement Therapy by Countries
      • 6.1.1 North America Testosterone Replacement Therapy Sales by Countries
      • 6.1.2 North America Testosterone Replacement Therapy Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Testosterone Replacement Therapy by Product
    • 6.3 North America Testosterone Replacement Therapy by End User

    7 Europe

    • 7.1 Europe Testosterone Replacement Therapy by Countries
      • 7.1.1 Europe Testosterone Replacement Therapy Sales by Countries
      • 7.1.2 Europe Testosterone Replacement Therapy Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Testosterone Replacement Therapy by Product
    • 7.3 Europe Testosterone Replacement Therapy by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Testosterone Replacement Therapy by Countries
      • 8.1.1 Asia Pacific Testosterone Replacement Therapy Sales by Countries
      • 8.1.2 Asia Pacific Testosterone Replacement Therapy Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Testosterone Replacement Therapy by Product
    • 8.3 Asia Pacific Testosterone Replacement Therapy by End User

    9 Central & South America

    • 9.1 Central & South America Testosterone Replacement Therapy by Countries
      • 9.1.1 Central & South America Testosterone Replacement Therapy Sales by Countries
      • 9.1.2 Central & South America Testosterone Replacement Therapy Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Testosterone Replacement Therapy by Product
    • 9.3 Central & South America Testosterone Replacement Therapy by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Testosterone Replacement Therapy by Countries
      • 10.1.1 Middle East and Africa Testosterone Replacement Therapy Sales by Countries
      • 10.1.2 Middle East and Africa Testosterone Replacement Therapy Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Testosterone Replacement Therapy by Product
    • 10.3 Middle East and Africa Testosterone Replacement Therapy by End User

    11 Company Profiles

    • 11.1 AbbVie
      • 11.1.1 AbbVie Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AbbVie Testosterone Replacement Therapy Products Offered
      • 11.1.5 AbbVie Recent Development
    • 11.2 Endo International
      • 11.2.1 Endo International Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Endo International Testosterone Replacement Therapy Products Offered
      • 11.2.5 Endo International Recent Development
    • 11.3 Eli lilly
      • 11.3.1 Eli lilly Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Eli lilly Testosterone Replacement Therapy Products Offered
      • 11.3.5 Eli lilly Recent Development
    • 11.4 Pfizer
      • 11.4.1 Pfizer Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Pfizer Testosterone Replacement Therapy Products Offered
      • 11.4.5 Pfizer Recent Development
    • 11.5 Actavis (Allergan)
      • 11.5.1 Actavis (Allergan) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Actavis (Allergan) Testosterone Replacement Therapy Products Offered
      • 11.5.5 Actavis (Allergan) Recent Development
    • 11.6 Bayer
      • 11.6.1 Bayer Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bayer Testosterone Replacement Therapy Products Offered
      • 11.6.5 Bayer Recent Development
    • 11.7 Novartis
      • 11.7.1 Novartis Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Novartis Testosterone Replacement Therapy Products Offered
      • 11.7.5 Novartis Recent Development
    • 11.8 Teva
      • 11.8.1 Teva Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Teva Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Teva Testosterone Replacement Therapy Products Offered
      • 11.8.5 Teva Recent Development
    • 11.9 Mylan
      • 11.9.1 Mylan Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Mylan Testosterone Replacement Therapy Products Offered
      • 11.9.5 Mylan Recent Development
    • 11.10 Upsher-Smith
      • 11.10.1 Upsher-Smith Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Upsher-Smith Testosterone Replacement Therapy Products Offered
      • 11.10.5 Upsher-Smith Recent Development
    • 11.11 Ferring Pharmaceuticals
    • 11.12 Kyowa Kirin
    • 11.13 Acerus Pharmaceuticals

    12 Future Forecast

    • 12.1 Testosterone Replacement Therapy Market Forecast by Regions
      • 12.1.1 Global Testosterone Replacement Therapy Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Testosterone Replacement Therapy Revenue Forecast by Regions 2019-2025
    • 12.2 Testosterone Replacement Therapy Market Forecast by Product
      • 12.2.1 Global Testosterone Replacement Therapy Sales Forecast by Product 2019-2025
      • 12.2.2 Global Testosterone Replacement Therapy Revenue Forecast by Product 2019-2025
    • 12.3 Testosterone Replacement Therapy Market Forecast by End User
    • 12.4 North America Testosterone Replacement Therapy Forecast
    • 12.5 Europe Testosterone Replacement Therapy Forecast
    • 12.6 Asia Pacific Testosterone Replacement Therapy Forecast
    • 12.7 Central & South America Testosterone Replacement Therapy Forecast
    • 12.8 Middle East and Africa Testosterone Replacement Therapy Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Testosterone Replacement Therapy Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
      Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

      The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

      The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.

      Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.

      North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

      North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.

      Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)
      Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

      The global Testosterone Replacement Therapy market is valued at 1820 million US$ in 2018 and will reach 1300 million US$ by the end of 2025, growing at a CAGR of -4.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Testosterone Replacement Therapy market based on company, product type, end user and key regions.

      This report studies the global market size of Testosterone Replacement Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Testosterone Replacement Therapy in these regions.
      This research report categorizes the global Testosterone Replacement Therapy market by top players/brands, region, type and end user. This report also studies the global Testosterone Replacement Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AbbVie
      Endo International
      Eli lilly
      Pfizer
      Actavis (Allergan)
      Bayer
      Novartis
      Teva
      Mylan
      Upsher-Smith
      Ferring Pharmaceuticals
      Kyowa Kirin
      Acerus Pharmaceuticals

      Market size by Product
      Gels
      Injections
      Patches
      Other
      Market size by End User
      Hospitals
      Clinics
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Testosterone Replacement Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Testosterone Replacement Therapy market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Testosterone Replacement Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Testosterone Replacement Therapy submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Testosterone Replacement Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Testosterone Replacement Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now